Association between C677T and A1298C MTHFR gene polymorphism and nonsyndromic orofacial clefts in the Turkish population: A case-parent study

Turkish Journal of Pediatrics

Volumn 54, Issue 6, 2012, Pages 617-625

  Semiç Jusufagiç, Aida ^a   Bircan, Rifat ^a   Çelebiler, Özhan ^a   Erdim, Melike ^a   Akarsu, Nurten ^b   Elçioǧlu, Nursel H ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

MTHFR polymorphisms; Nonsyndromic cleft lip palate; Transmission disequilibrium test

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADOLESCENT; ADULT; ARTICLE; CLEFT LIP PALATE; CLEFT PALATE; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; FOLATE METABOLISM; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; MOTHER; NONSYNDROMIC CLEFT LIP PALATE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TRANSMISSION DISEQUILIBRIUM TEST ANALYSIS; TURKISH; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ALLELES; BRAIN; CHILD; CHILD, PRESCHOOL; CLEFT LIP; CLEFT PALATE; DNA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PARENTS; POLYMORPHISM, GENETIC; RISK FACTORS; TURKEY; YOUNG ADULT;

EID: 84876096274     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Carinci F, Pezzetti F, Scapoli L, et al. Recent developments in orofacial cleft genetics. J Craniofac Surg 2003; 14: 130-143.
2. Prescott NJ, Winter RM, Malcolm S. Nonsyndromic cleft lip and palate: complex genetics and environmental effects. Ann Hum Genet 2001; 65: 505-515.
3. Wilcox AJ, Lie RT, Solvoll K, et al. Folic acid supplements and risk of facial clefts: national population based case-control study. BMJ 2007; 334: 464.
4. Badovinac RL, Werler MM, Williams PL, Kelsey K T, Hayes C. Folic acid-containing supplement consumption during pregnancy and risk for oral clefts: a meta-analysis. Birth Defects Res A Clin Mol Teratol 2007; 79: 8-15.
5. Limpach A, Dalton M, Miles R, Gadson P. Homocysteine inhibits retinoic acid synthesis: a mechanism for homocysteine-induced congenital defects. Exp Cell Res 2000; 260: 166-174.
6. Greene ND, Dunlevy LE, Copp AJ. Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat Embryol (Berl) 2003; 206: 185-191.
7. Van der Put NM, Steegers-Theunissen R P, Frosst P, et al. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995; 346: 1070-1071.
8. Van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044-1051.
9. Junker R, Kotthoff S, Vielhaber H, et al. Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease. Cardiovasc Res 2001; 51: 251-254.
10. Mills JL, Kirke PN, Molloy AM, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 1999; 86: 71-74.
11. Prescott NJ, Winter RM, Malcolm S. Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palate. J Med Genet 2002; 39: 368-369.
12. Shaw GM, Rozen R, Finnell RH, Todoroff K, Lammer EJ. Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet 1998; 80: 196-198.
13. Shotelersuk V, Ittiwut C, Siriwan P, Angspatt A. Maternal 677CT/1298AC genotype of the MTHFR gene as a risk factor for cleft lip. J Med Genet 2003; 40: e64.
14. Gaspar DA, Pavanello RC, Zatz M, et al. Role of the C677T polymorphism at the MTHFR gene on risk to nonsyndromic cleft lip with/without cleft palate: results from a case-control study in Brazil. Am J Med Genet 1999; 87: 197-199.
15. Blanton SH, Patel S, Hecht JT, Mulliken JB. MTHFR is not a risk factor in the development of isolated nonsyndromic cleft lip and palate. Am J Med Genet 2002; 110: 404-405.
16. Jugessur A, Wilcox AJ, Lie RT, et al. Exploring the effects of methylenetetrahydrofolate reductase gene variants C677T and A1298C on the risk of orofacial clefts in 261 Norwegian case-parent triads. Am J Epidemiol 2003; 157: 1083-1091.
17. Martinelli M, Scapoli L, Pezzetti F, et al. C677T variant form at the MTHFR gene and CL/P: a risk factor for mothers? Am J Med Genet 2001; 98: 357-360.
18. Pezzetti F, Martinelli M, Scapoli L, et al. Maternal MTHFR variant forms increase the risk in offspring of isolated nonsyndromic cleft lip with or without cleft palate. Hum Mutat 2004; 24: 104-105.
19. van Rooij IA, Vermeij-Keers C, Kluijtmans LA, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate? Am J Epidemiol 2003; 157: 583-591.
20. Chevrier C, Perret C, Bahuau M, et al. Fetal and maternal MTHFR C677T genotype, maternal folate intake and the risk of nonsyndromic oral clefts. Am J Med Genet A 2007; 143: 248-257.
21. Akar N, Akar E, Deda G, Arsan S. Spina bifida and common mutations at the homocysteine metabolism pathway. Clin Genet 2000; 57: 230-231.
22. Boduroglu K, Alikasifoglu M, Anar B, Tuncbilek E. Association of the 677C-->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects. J Child Neurol 1999; 14: 159-161.
23. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
24. Vujkovic M, Steegers EA, van Meurs J, et al. The maternal homocysteine pathway is influenced by riboflavin intake and MTHFR polymorphisms without affecting the risk of orofacial clefts in the offspring. Eur J Clin Nutr 2010; 64: 266-273.
25. Boyles AL, Wilcox AJ, Taylor JA, et al. Folate and one-carbon metabolism gene polymorphisms and their associations with oral facial clefts. Am J Med Genet A 2008; 146A: 440-449.
26. Verkleij-Hagoort A, Bliek J, Sayed-Tabatabaei F, et al. Hyperhomocysteinemia and MTHFR polymorphisms in association with orofacial clefts and congenital heart defects: a meta-analysis. Am J Med Genet A 2007; 143A: 952-960.
27. Zhu J, Hao L, Li S, Bailey LB, Tian Y, Li Z. MTHFR, TGFB3, and TGFA polymorphisms and their association with the risk of non-syndromic cleft lip and cleft palate in China. Am J Med Genet A 2010; 152A: 291-298.
28. Zhu J, Ren A, Hao L, et al. Variable contribution of the MTHFR C677T polymorphism to non-syndromic cleft lip and palate risk in China. Am J Med Genet A 2006; 140: 551-557.
29. Xiao WL, Wu M, Shi B. Folic acid rivals methylenetetrahydrofolate reductase (MTHFR) gene-silencing effect on MEPM cell proliferation and apoptosis. Mol Cell Biochem 2006; 292: 145-154.
30. Blom HJ, Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 2011; 34: 75-81.
31. Weisberg IS, Jacques P F, Selhub J, et al. The 1298A->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415.